Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual PET AV-133 in PD
NCT07830654Phase 2Recruiting
- Sponsor
- The Michael J. Fox Foundation for Parkinson's Research
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of Florbenazine F-18 in Parkinson's disease (PD), sponsored by The Michael J. Fox Foundation for Parkinson's Research. Started Sep 2025; status: recruiting.
02
Drugs
Florbenazine F-18
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07830654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07830654.